Pathophysiological Concepts in Multiple Sclerosis and the Therapeutic Effects of Hydrogen Sulfide

Introduction: Multiple sclerosis (MS) is generally known as a manageable but not yet curable autoimmune disease affecting central nervous system. A potential therapeutic approach should possess several properties: Prevent immune system from damaging the brain and spinal cord,&n...

Full description

Bibliographic Details
Main Author: Fatemeh Talaei
Format: Article
Language:English
Published: Iran University of Medical Sciences 2016-04-01
Series:Basic and Clinical Neuroscience
Subjects:
Online Access:http://bcn.iums.ac.ir/browse.php?a_code=A-10-782-1&slc_lang=en&sid=1
_version_ 1827334507361992704
author Fatemeh Talaei
author_facet Fatemeh Talaei
author_sort Fatemeh Talaei
collection DOAJ
description Introduction: Multiple sclerosis (MS) is generally known as a manageable but not yet curable autoimmune disease affecting central nervous system. A potential therapeutic approach should possess several properties: Prevent immune system from damaging the brain and spinal cord, promote differentiation of oligodendrocyte progenitor cells (OPCs) into mature oligodendrocytes to produce myelin, prevent the formation of fibronectin aggregates by astrocytes to inhibit scar formation, and enhance function of healthy endothelial cells (ECs). Methods: To determine if an increase in sulfur contents through H2S, a potent antioxidant known to induce protective autophagy in cells, could provide the above desired outcomes, peripheral blood mononuclear cells (PBMNCs), OCPs, astrocytes, and ECs were treated with NaHS (50 μM) in vitro. Results: Transmigration assay using EC monolayer showed that serotonin increased migration of PBMNC while pretreatment of EC with NaHS inhibited the migration induced by serotonin treatment. NaHS upregulated proteins involved in immune system response and downregulated PBMNCs- and EC-related adhesion molecules (LFA-1 and VCAM-1). Furthermore, it had a cell expansion inducing effect, altering EC morphology. The effects of NaHS on OPCs and astrocytes were studied compared to mTOR inhibitor rapamycin. In NaHS treated astrocytes the induced fibronectin production was partially inhibited while rapamycin almost fully inhibited fibronectin production. NaHS slowed but did not inhibit the differentiation of OCPs or the production of myelin compared to rapamycin. Conclusion: The in vitro results point to the potential therapeutic application of hydrogen sulfide releasing molecules or health-promoting sulfur compounds in MS.
first_indexed 2024-03-07T17:55:39Z
format Article
id doaj.art-3ba7f9ca76d9474589d2dfd16f51cd41
institution Directory Open Access Journal
issn 2008-126X
2228-7442
language English
last_indexed 2024-03-07T17:55:39Z
publishDate 2016-04-01
publisher Iran University of Medical Sciences
record_format Article
series Basic and Clinical Neuroscience
spelling doaj.art-3ba7f9ca76d9474589d2dfd16f51cd412024-03-02T12:15:54ZengIran University of Medical SciencesBasic and Clinical Neuroscience2008-126X2228-74422016-04-0172121136Pathophysiological Concepts in Multiple Sclerosis and the Therapeutic Effects of Hydrogen SulfideFatemeh Talaei0 Novel Drug Delivery Systems Lab, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran. Introduction: Multiple sclerosis (MS) is generally known as a manageable but not yet curable autoimmune disease affecting central nervous system. A potential therapeutic approach should possess several properties: Prevent immune system from damaging the brain and spinal cord, promote differentiation of oligodendrocyte progenitor cells (OPCs) into mature oligodendrocytes to produce myelin, prevent the formation of fibronectin aggregates by astrocytes to inhibit scar formation, and enhance function of healthy endothelial cells (ECs). Methods: To determine if an increase in sulfur contents through H2S, a potent antioxidant known to induce protective autophagy in cells, could provide the above desired outcomes, peripheral blood mononuclear cells (PBMNCs), OCPs, astrocytes, and ECs were treated with NaHS (50 μM) in vitro. Results: Transmigration assay using EC monolayer showed that serotonin increased migration of PBMNC while pretreatment of EC with NaHS inhibited the migration induced by serotonin treatment. NaHS upregulated proteins involved in immune system response and downregulated PBMNCs- and EC-related adhesion molecules (LFA-1 and VCAM-1). Furthermore, it had a cell expansion inducing effect, altering EC morphology. The effects of NaHS on OPCs and astrocytes were studied compared to mTOR inhibitor rapamycin. In NaHS treated astrocytes the induced fibronectin production was partially inhibited while rapamycin almost fully inhibited fibronectin production. NaHS slowed but did not inhibit the differentiation of OCPs or the production of myelin compared to rapamycin. Conclusion: The in vitro results point to the potential therapeutic application of hydrogen sulfide releasing molecules or health-promoting sulfur compounds in MS.http://bcn.iums.ac.ir/browse.php?a_code=A-10-782-1&slc_lang=en&sid=1NaHS Fibronectin Myelin Astrocytes Oligodendrocytes HUVEC Peripheral Blood Mononuclear Cells
spellingShingle Fatemeh Talaei
Pathophysiological Concepts in Multiple Sclerosis and the Therapeutic Effects of Hydrogen Sulfide
Basic and Clinical Neuroscience
NaHS
Fibronectin
Myelin
Astrocytes
Oligodendrocytes
HUVEC
Peripheral Blood Mononuclear Cells
title Pathophysiological Concepts in Multiple Sclerosis and the Therapeutic Effects of Hydrogen Sulfide
title_full Pathophysiological Concepts in Multiple Sclerosis and the Therapeutic Effects of Hydrogen Sulfide
title_fullStr Pathophysiological Concepts in Multiple Sclerosis and the Therapeutic Effects of Hydrogen Sulfide
title_full_unstemmed Pathophysiological Concepts in Multiple Sclerosis and the Therapeutic Effects of Hydrogen Sulfide
title_short Pathophysiological Concepts in Multiple Sclerosis and the Therapeutic Effects of Hydrogen Sulfide
title_sort pathophysiological concepts in multiple sclerosis and the therapeutic effects of hydrogen sulfide
topic NaHS
Fibronectin
Myelin
Astrocytes
Oligodendrocytes
HUVEC
Peripheral Blood Mononuclear Cells
url http://bcn.iums.ac.ir/browse.php?a_code=A-10-782-1&slc_lang=en&sid=1
work_keys_str_mv AT fatemehtalaei pathophysiologicalconceptsinmultiplesclerosisandthetherapeuticeffectsofhydrogensulfide